PURPOSE: The purpose of this study was to assess the relationship between donor factors and 5-year corneal graft survival in the Cornea Donor Study. METHODS: Donor corneas met criteria established by the Eye Bank Association of America, had an endothelial cell density of 2300 to 3300/mm, and were determined to be of good to excellent quality by the eye banks. Donor corneas were assigned using a random approach and surgeons were masked to information about the donor cornea including donor age. Surgery and postoperative care were performed according to the surgeons' usual routines and subjects were followed for 5 years. Donor and donor cornea factors were evaluated for their association with graft failure, which was defined as a regraft or a cloudy cornea that was sufficiently opaque to compromise vision for a minimum of 3 consecutive months. RESULTS: Graft failure was not significantly associated with the type of tissue retrieval (enucleation versus in situ), processing factors, timing of use of the cornea, or characteristics of the donor or the donor cornea. Adjusting for donor age did not affect the results. CONCLUSION: Donor and donor cornea characteristics do not impact graft survival rates for corneas comparable in quality to those used in this study.
PURPOSE: The purpose of this study was to assess the relationship between donor factors and 5-year corneal graft survival in the Cornea Donor Study. METHODS:Donor corneas met criteria established by the Eye Bank Association of America, had an endothelial cell density of 2300 to 3300/mm, and were determined to be of good to excellent quality by the eye banks. Donor corneas were assigned using a random approach and surgeons were masked to information about the donor cornea including donor age. Surgery and postoperative care were performed according to the surgeons' usual routines and subjects were followed for 5 years. Donor and donor cornea factors were evaluated for their association with graft failure, which was defined as a regraft or a cloudy cornea that was sufficiently opaque to compromise vision for a minimum of 3 consecutive months. RESULTS:Graft failure was not significantly associated with the type of tissue retrieval (enucleation versus in situ), processing factors, timing of use of the cornea, or characteristics of the donor or the donor cornea. Adjusting for donor age did not affect the results. CONCLUSION:Donor and donor cornea characteristics do not impact graft survival rates for corneas comparable in quality to those used in this study.
Authors: Mark J Mannis; Edward J Holland; Roy W Beck; Michael W Belin; Marc A Goldberg; Robin L Gal; Andrea D Kalajian; Kenneth R Kenyon; Craig Kollman; Katrina J Ruedy; Patricia Smith; Joel Sugar; Walter J Stark Journal: Cornea Date: 2006-02 Impact factor: 2.651
Authors: Alan Sugar; Robin L Gal; roy W Beck; Katrina J Ruedy; Christopher L Blanton; Robert S Feder; David R Hardten; Edward J Holland; Jonathan H Lass; Mark J Mannis; Michael B O'Keefe Journal: Cornea Date: 2005-05 Impact factor: 2.651
Authors: Robin L gal; Mariya Dontchev; Roy W Beck; Mark J Mannis; Edward J Holland; Craig Kollman; Steven P Dunn; Ellen L Heck; Jonathan H Lass; Monty M Montoya; Robert L Schultze; R Doyle Stulting; Alan Sugar; Joel Sugar; Bradley Tennant; David D Verdier Journal: Ophthalmology Date: 2008-04 Impact factor: 12.079
Authors: Sohela S Hassan; Kirk R Wilhelmus; Patricia Dahl; Gregory C Davis; Russell T Roberts; Kevin W Ross; Bruce H Varnum Journal: Arch Ophthalmol Date: 2008-02
Authors: Jonathan H Lass; Tonya D Riddlesworth; Robin L Gal; Craig Kollman; Beth A Benetz; Francis W Price; Alan Sugar; Mark A Terry; Mark Soper; Roy W Beck Journal: Ophthalmology Date: 2014-11-15 Impact factor: 12.079
Authors: Alan Sugar; Monty M Montoya; Roy Beck; John W Cowden; Mariya Dontchev; Robin L Gal; Craig Kollman; Jackie Malling; Mark J Mannis; Bradley Tennant Journal: Cornea Date: 2012-12 Impact factor: 2.651
Authors: Jonathan H Lass; Roy W Beck; Beth Ann Benetz; Mariya Dontchev; Robin L Gal; Edward J Holland; Craig Kollman; Mark J Mannis; Francis Price; Irving Raber; Walter Stark; R Doyle Stulting; Alan Sugar Journal: Arch Ophthalmol Date: 2011-05-09
Authors: Alan Sugar; Robin L Gal; Craig Kollman; Dan Raghinaru; Mariya Dontchev; Christopher R Croasdale; Robert S Feder; Edward J Holland; Jonathan H Lass; Jonathan I Macy; Mark J Mannis; Patricia W Smith; Sarkis H Soukiasian; Roy W Beck Journal: JAMA Ophthalmol Date: 2015-03 Impact factor: 7.389
Authors: Beth Ann Benetz; Jonathan H Lass; Robin L Gal; Alan Sugar; Harry Menegay; Mariya Dontchev; Craig Kollman; Roy W Beck; Mark J Mannis; Edward J Holland; Mark Gorovoy; Sadeer B Hannush; John E Bokosky; James W Caudill Journal: JAMA Ophthalmol Date: 2013-05 Impact factor: 7.389
Authors: David D Verdier; Alan Sugar; Keith Baratz; Roy Beck; Mariya Dontchev; Steven Dunn; Robin L Gal; Edward J Holland; Craig Kollman; Jonathan H Lass; Mark J Mannis; Jeffrey Penta Journal: Cornea Date: 2013-06 Impact factor: 2.651
Authors: Kevin W Ross; Christopher G Stoeger; George O D Rosenwasser; Robert C OʼBrien; Loretta B Szczotka-Flynn; Allison R Ayala; Maureen G Maguire; Beth Ann Benetz; Patricia Dahl; Donna C Drury; Steven P Dunn; Sameera M Farazdaghi; Caroline K Hoover; Marian S Macsai; Shahzad I Mian; Michael L Nordlund; Jeffrey G Penta; Mark C Soper; Mark A Terry; David D Verdier; Doyce V Williams; Jonathan H Lass Journal: Cornea Date: 2019-09 Impact factor: 3.152